Natixis Advisors LLC Has $557,000 Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Natixis Advisors LLC significantly reduced its stake in Acadia Healthcare by 90.6%, selling 176,920 shares and retaining 18,371 shares worth approximately $557,000.
• Acadia Healthcare's stock has seen several analysts' ratings changes, with upgrades to "hold" and price target revisions ranging from $31.00 to $55.00.
• The company reported a 9.2% increase in revenue year-over-year, achieving $869.23 million, and beat the earnings per share consensus estimate of $0.71 by $0.12.

Natixis Advisors LLC lowered its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 90.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,371 shares of the company's stock after selling 176,920 shares during the period. Natixis Advisors LLC's holdings in Acadia Healthcare were worth $557,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ACHC. UMB Bank n.a. lifted its position in Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after acquiring an additional 755 shares during the last quarter. State of Wyoming acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at $56,000. Covestor Ltd raised its stake in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after buying an additional 310 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in shares of Acadia Healthcare in the 4th quarter valued at $97,000. Finally, GAMMA Investing LLC boosted its stake in shares of Acadia Healthcare by 143.8% in the 1st quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock valued at $176,000 after purchasing an additional 3,428 shares in the last quarter.

Acadia Healthcare Trading Up 2.2%

Shares of ACHC traded up $0.44 during trading hours on Wednesday, hitting $20.77. 2,941,541 shares of the stock traded hands, compared to its average volume of 2,226,614. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare Company, Inc. has a 1-year low of $17.13 and a 1-year high of $82.40. The firm has a market capitalization of $1.92 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 3.96 and a beta of 0.88. The business has a fifty day moving average of $22.05 and a 200-day moving average of $27.38.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%. The business had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same quarter in the prior year, the firm posted $0.91 earnings per share. The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. Analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently commented on ACHC shares. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. Guggenheim reduced their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating on the stock in a research note on Thursday, August 7th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Mizuho set a $22.00 target price on shares of Acadia Healthcare in a research note on Wednesday. Finally, Cowen restated a "buy" rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $42.25.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.